Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis and HIV news

Show

From To
Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

Drinking three or more cups of coffee a day halves the risk of death from any cause for people with HIV/hepatitis C virus (HCV) co-infection,

Published
03 October 2017
By
Michael Carter
Is HCV Drug Development Nearing Its End?

The FDA recently approved two new combination regimens for hepatitis C, raising the question of whether further drug development is warranted in this area. Experts agree, however, that more remains to be done in terms of implementation: getting everyone at risk screened for HCV infection, and getting those who test positive on effective treatment.

Published
02 October 2017
From
MedPage Today
VA models provide guidance for care of hepatitis C infection

The U.S. Department of Veterans Affairs (VA) has developed models of care that can be used to reduce the overall burden of hepatitis C virus (HCV) infection, according to a study published online Sept. 25 in the Annals of Internal Medicine.

Published
28 September 2017
From
Medical Xpress
Death toll from San Diego hepatitis outbreak rises to 17, with no signs of slowing

The death toll in San Diego’s hepatitis A outbreak increased Tuesday, and the region’s top public health official said she hasn’t seen any signs of a slowdown in the public health emergency that has now killed 17 people.

Published
28 September 2017
From
Los Angeles Times
US FDA approves nivolumab immunotherapy for liver cancer

The US Food and Drug Administration (FDA) last week granted accelerated approval for nivolumab (Opdivo), an immunotherapy drug that restores T-cell anti-tumour activity, for people

Published
28 September 2017
By
Liz Highleyman
No, there isn’t a hepatitis cure ‘for hipsters’ with a £35,000 price tag and own clothing line

A new hepatitis C drug costing ‘just’ £2,000-a-month for 18 months (£36,000) was ‘launched’ on the web with a fancy video and young people showing off the new ‘exclusive’ drug to cure hepatitis C.

Published
27 September 2017
From
Metro
Hepatitis A increase in NYC linked to travel among MSM

According to the CDC, the New York City Department of Health and Mental Hygiene reported an increase in hepatitis A infection among men who have sex with men in the city this year. Further, some of these men report traveling to areas in Western Europe where HAV outbreaks are ongoing among MSM.

Published
26 September 2017
From
Healio
Gay men with hepatitis C are suffering stigma not seen since the HIV/AIDS crisis

It seems that hepatitis C has taken on the stigma and fear that HIV once carried. But as an illness that also disproportionately affects gay and bisexual men, it seems that awareness and education remains woefully low.

Published
25 September 2017
From
Attitude
Does drug injection equipment other than syringes transmit hepatitis C?

Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal

Published
20 September 2017
By
Liz Highleyman
Viral Hepatitis kills more people than HIV, malaria or tuberculosis

According to the Global Burden of Disease study released today, deaths caused by viral hepatitis have surpassed all chronic infectious diseases including HIV/AIDS, malaria and tuberculosis.

Published
18 September 2017
From
World Hepatitis Alliance

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.